| | |||||||
| lose weight | |||||||
| NEWS | |||||||
GLP-1 Weight-Loss Injections May Pose 'Hidden Risks' to Young Women - Newsweek GLP-1 receptor agonists—the popular class of weight-loss drugs that include semaglutide (Ozempic)—may carry underrecognized risks for women of ...
| |||||||
| See more results | Edit this alert | |||||||
| You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
| Send Feedback |